(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol

C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C

InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,23-,24+,25+,27-/m1/s1

GMRQFYUYWCNGIN-NKMMMXOESA-N

calcitriol; 32222-06-3; Rocaltrol; Calcijex; Topitriol; 1alpha,25-Dihydroxyvitamin D3; Silkis; 1alpha,25-Dihydroxycholecalciferol; Soltriol; Vectical; 1,25-DHCC; 1,25-DIHYDROXYCHOLECALCIFEROL; 1,25-Dihydroxyvitamin D3; 1,25-Dihydroxyvitamin D; Calcitriolum; 1alpha,25(OH)2D3; Ro 21-5535; Dihydroxyvitamin D3; 1-alpha,25-Dihydroxyvitamin D3; DN-101; CHEMBL846; (1S,3R,5Z,7E)-9,10-secocholesta-5,7,10-triene-1,3,25-triol; 1a,25-Dihydroxyvitamin D3; FXC9231JVH; Ro-21-5535; 1a,25-Dihydroxycholecalciferol; CHEBI:17823; 1-alpha-25-dihydroxyvitamin D3; vit D; (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol; (1R,3S,Z)-5-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol; Ro-215535; NCGC00161327-04; DN 101; (5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1alpha,3beta,25-triol; (1alpha,3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol; (5Z,7E)-(1S,3R)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol; 9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1a,3b,5Z,7E)-; Ro 215535; 1,25-dihydroxy vitamin D3; Toptriol; 1000873-74-4; 1alpha,25-Dihydroxyvitamin D; Decostriol; (1S,3R,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol; (5Z,7E)-(1S,3R)-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol; Calcitriolum [INN-Latin]; 1alpha,25-dihydroxyvitamin D3 / 1alpha,25-dihydroxycholecalciferol / calcitriol; Calcitriol (Rocaltrol); 1,25-Dihydroxycholecaliferol; SMR000466393; 1,25 (OH)2 D3; CCRIS 5522; dihydroxy-vitamin D3; HSDB 3482; EINECS 250-963-8; UNII-FXC9231JVH; 1,25-(OH)2D3; Asentar; Panbonis; 1,25 Dihydroxycholecalciferol; 1,25-(OH)2-D3; 1.alpha.,25-dihydroxycholecalciferol; 9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1.alpha.,3.beta.,5Z,7E)-; 1alpha 25-dihydroxycholecalciferol; Rocaltrol (TN); (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-5-hydroxy-1,5-dimethyl-hexyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol; 5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL; U 49562; MFCD00867079; Calcitriol [USAN:USP:INN:BAN:JAN]; Cholecalciferol, 1-alpha,25-dihydroxy-; 1db1; starbld0021993; CALCITRIOL [MI]; CALCITRIOL [INN]; CALCITRIOL [JAN]; Spectrum5_002061; CALCITRIOL [HSDB]; CALCITRIOL [USAN]; 9,10-Seco(5Z,7E)-5,7,10(19)-cholestatriene-1alpha,3beta,25-triol; DSSTox_CID_2722; CALCITRIOL [VANDF]; 25-dihydroxycholecalciferol; 9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1alpha,3beta,5Z,7E)-; CALCITRIOL [MART.]; SCHEMBL3245; CALCITRIOL [USP-RS]; CALCITRIOL [WHO-DD]; DSSTox_RID_76700; 1alpha,25(OH)2-D3; DSSTox_GSID_22722; BSPBio_001287; Calcitriol (JAN/USP/INN); MLS000759536; MLS001424122; 1|A,25-Dihydroxyvitamin D3; BML2-E03; GTPL2779; (1S,3R,5Z,7E)-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol; CALCITRIOL [ORANGE BOOK]; DTXSID5022722; BCBcMAP01_000160; CHEBI:93988; CALCITRIOL [EP MONOGRAPH]; Cas Number 32222-06-3; BCPP000304; CALCITRIOL [USP MONOGRAPH]; HMS1361A09; HMS1791A09; HMS1989A09; HMS2051F06; HMS2089N03; HMS2232D18; HMS3402A09; 1 alpha ,25-Dihydroxyvitamin D3; ACT06832; EX-A4435; 1,25 DIHYDROXY VITAMIN D3; 1a,25-(OH)2D3; Tox21_111988; BDBM50200182; LMST03020258; NSC749776; s1466; 1-alpha,-1,25-Dihydroxyvitamin D3; AKOS015961898; ZINC100015048; AC-1859; BCP9000474; CCG-101001; CD-2027; CS-0388; DB00136; NC00251; NSC-749776; 1,25(OH2)D3; IDI1_033757; 1,25(OH)2D3 & CD4; Calcitrol 100 microg/mL in Acetonitrile; NCGC00161327-01; (1R,3S,Z)-5-(2-((1R,3aS,7aR,E)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol; 1.alpha.,25-Dihydroxyvitamin D(sub 3); CPD000466393; HY-10002; RO215535; CAS-32222-06-3; Vitamin D3-1alpha,25-dihydroxy (Calcitriol); 1,25D3; C01673; D00129; AB00639957-06; AB00639957_07; 1,25-DIHYDROXYCHOLECALCIFEROL, (1ALPHA)-; 1alpha,25-Dihydroxyvitamin D3, >=99% (HPLC); 222C063; EN300-22411582; Q139195; SR-01000759361; SR-01000946978; 1alpha,25-Dihydroxyvitamin D3, >=97.0% (HPLC); SR-01000759361-4; SR-01000946978-1; 1.Alpha.,25-Dihydroxy-26,27-hexadeuterovitamin D3; BRD-K27316855-001-06-7; BRD-K27316855-001-19-0; (3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trienetriol; Calcitriol, European Pharmacopoeia (EP) Reference Standard; (1?,3?,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol; (5Z,10-secocholesta-5,7,10(19)-triene-1.alpha.,3.beta.,25-triol; (1S,3R,5Z,7E,14beta,17alpha)-9,10-secocholesta-5,7,10-triene-1,3,25-triol; 9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1.alpha.,3.beta,.5Z,7E)-; 9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1.alpha.,3.beta,.5Z,7E)- & CD4; (1R,3S)-5-{2-[(1R,3aS,7aR)-1-((R)-5-Hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol; (1R,3S,5Z)-5-{2-[(1R,3aS,4E,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexane-1,3-diol; 1,3-Cyclohexanediol, 4-methylene-5-[2-[(1R,3aS,7aR)-octahydro-1-[(1R)-5-hydroxy-1,5-dimethylhexyl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-, (1R,3S)-